Authors
Loading...
Cohort study reveals reduced survival in non-Hodgkin lymphoma patients with co-elevated serum VEGF and bFGF, indicating strong independent prognostic utility.
Salvén et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: